Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 A.m. ET.
BofA Securities Maintains Esperion Therapeutics(ESPR.US) With Sell Rating, Maintains Target Price $2.05
Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference
Esperion Therapeutics Completes Financing Deals to Partially Repay Convertible Debt
Express News | Esperion Strengthens Balance Sheet With Closing of Significant Refinancing Transactions
Goldman Sachs Upgrades Esperion Therapeutics(ESPR.US) to Hold Rating, Raises Target Price to $4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
152218720 : I've been holding onto this since last October and still waiting.